Why is Global Health falling/rising?

As of 25-Jun, Global Health Ltd is currently priced at 1,129.50, reflecting a slight increase of 1.5 (0.13%). However, the stock has underperformed its sector today by 1.4%, and it is trading below all its moving averages, indicating a bearish trend. Over the past week, the stock has decreased by 3.46%, and it has also shown a decline of 7.10% over the past month. Despite a year-to-date return of 4.29%, the stock has faced significant challenges, including a year-over-year decline of 11.85%. The company's management efficiency is notable, with a high return on equity (ROE) of 15.90% and a low debt-to-equity ratio, but it is trading at a premium valuation compared to its peers, which may deter investors. Additionally, the flat results reported in March, with the lowest earnings per share (EPS) at Rs 3.78, contribute to the negative sentiment surrounding the stock. In the broader market context, Global Health's recent performance contrasts sharply with the Sensex, which has gained 1.61% over the past week. The stock's underperformance is further highlighted by its negative returns over the past year and its inability to keep pace with the BSE 500 index in both the short and long term. The decline in delivery volume by 35.67% against the five-day average suggests falling investor participation, which may indicate a lack of confidence in the stock's future prospects. While institutional holdings have increased, suggesting some level of confidence from larger investors, the overall market sentiment remains cautious due to the company's expensive valuation and underwhelming performance metrics.